Show All

Cargo Therapeutics was founded in December 2019.

Cargo Therapeutics was incorporated as a Delaware corporation in December 2019 under the name Syncopation Life Sciences, Inc. In September 2022, the name was formally changed to CARGO Therapeutics, Inc.

835 Industrial Road
Suite 400
San Carlos, CA 94070

You can view our Board of Directors by visiting the Board of Directors section of our website.

You can view our leadership team by visiting the Leadership Team section of our website.

December 31st.

Deloitte & Touche LLP

Cargo Therapeutics is traded on the NASDAQ Global Select Market under the symbol “CRGX”.

Cargo Therapeutics went public on 11/10/2023.

Shares can be purchased through a stockbroker of your choice.

Cargo Therapeutics does not offer a direct stock purchase plan.

Currently, Cargo Therapeutics does not offer a dividend or a dividend reinvestment program.

Our CUSIP Number is 14179K 101.

Cargo Therapeutics’ transfer agent is  Equiniti. Their customer service number is (800) 937-5449.

Equiniti Trust Company
6201 15th Ave
Brooklyn, NY 11219

 

Please contact our transfer agent, American Stock Transfer, by telephone at (800) 937-5449. American Stock Transfer can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates. Information is also available at www.astfinancial.com.

You must send both your old and new addresses to our transfer agent, American Stock Transfer, by U.S. mail. Each stockholder in question must sign the request for an address change. For more information and address change forms, contact American Stock Transfer by telephone at (800) 937-5449 or go to www.astfinancial.com.

Quarterly & Annual Reports and other investor materials, when available, can be found in the Financials section on the Investor Relations page of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.

You can view our recent press releases by visiting the Press Releases section of our website.

You can view information on our development programs by visiting the Pipeline section of our website.

For investor-related questions please send an email to ir@cargo-tx.com.

Please visit the Email Alerts section of our Investor Relations site and fill out our web form to be added to the Cargo Therapeutics distribution list.

To request additional information, please visit our Contact page.

A U.S. internal Revenue Service Form 8937 (Report of Organizational Actions Affecting Basis of Securities) for each of the reverse stock split effected by CARGO Therapeutics Inc., can be found at the following links:

Form 8937
Attachment to Form 8937
 

PLEASE CONSULT YOUR OWN TAX ADVISOR WITH RESPECT TO THE U.S. FEREDERAL INCOME AND OTHER U.S. FEDERAL, STATE, LOCAL OR NON-U.S. TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT, AS APPLICABLE TO YOUR OWN PERSONAL CIRCUMSTANCES.